80 related articles for article (PubMed ID: 33119174)
1. Prognosis of bulky pTIIB cervical cancer treated by radical hysterectomy comparing adenocarcinoma with squamous cell carcinoma using propensity score matching.
Okadome M; Nagayama R; Shimokawa M; Sonoda K; Shimamoto K; Saito T
Int J Gynaecol Obstet; 2021 Apr; 153(1):56-63. PubMed ID: 33119174
[TBL] [Abstract][Full Text] [Related]
2. Early-stage node negative cervical adenocarcinoma and squamous cell carcinoma show similar survival outcomes after hysterectomy: a population-based study.
Wu SG; Sun JY; He ZY; Chen QH; Zhou J
J Gynecol Oncol; 2017 Nov; 28(6):e81. PubMed ID: 29027399
[TBL] [Abstract][Full Text] [Related]
3. Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery.
Zhang X; Lv Z; Xu X; Yin Z; Lou H
BMC Cancer; 2020 Jul; 20(1):664. PubMed ID: 32678039
[TBL] [Abstract][Full Text] [Related]
4. Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14-year multicenter study.
Ye Y; Zhang G; Li Z; Chen B; Zhao H; Yang Y; Wang L; Yao J; Chen X; Huang Y; Lang J; Liu P; Chen C
Cancer Med; 2023 Oct; 12(19):19617-19632. PubMed ID: 37768092
[TBL] [Abstract][Full Text] [Related]
5. Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a subanalysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study.
Bizzarri N; Querleu D; Dostálek L; van Lonkhuijzen LRCW; Giannarelli D; Lopez A; Salehi S; Ayhan A; Kim SH; Ortiz DI; Klat J; Landoni F; Pareja R; Manchanda R; Kosťun J; Ramirez PT; Meydanli MM; Odetto D; Laky R; Zapardiel I; Weinberger V; Dos Reis R; Pedone Anchora L; Amaro K; Akilli H; Abu-Rustum NR; Salcedo-Hernández RA; Javůrková V; Mom CH; Scambia G; Falconer H; Cibula D
Am J Obstet Gynecol; 2023 Oct; 229(4):428.e1-428.e12. PubMed ID: 37336255
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors affecting survival and recurrence in patients with early cervical squamous cell cancer following radical hysterectomy.
Li D; Xu X; Yan D; Yuan S; Ni J; Lou H
J Int Med Res; 2020 Apr; 48(4):300060519889741. PubMed ID: 31889461
[TBL] [Abstract][Full Text] [Related]
7. Laparoscopic versus open radical hysterectomy in FIGO 2018 early-stage cervical adenocarcinoma: Long-term survival outcomes after propensity score matching.
Yin Z; Cui Z; Kang S; Ji M; Li D; Chen B; Zhan X; Li W; Liu P; Chen C
J Obstet Gynaecol Res; 2023 Dec; 49(12):2849-2859. PubMed ID: 37658744
[TBL] [Abstract][Full Text] [Related]
8. Salvage radiotherapy strategy and its prognostic significance for patients with locoregional recurrent cervical cancer after radical hysterectomy: a multicenter retrospective 10-year analysis.
Shan M; Deng Y; Zou W; Fan S; Li Y; Liu X; Wang J
BMC Cancer; 2023 Sep; 23(1):905. PubMed ID: 37752476
[TBL] [Abstract][Full Text] [Related]
9. Local treatment strategies in Stage IVB cervical squamous cell carcinoma and adenocarcinoma.
Xu JY; Hu M; Wu SG; Zhou J
Int J Gynaecol Obstet; 2024 Mar; 164(3):1053-1063. PubMed ID: 37724012
[TBL] [Abstract][Full Text] [Related]
10. Survival benefit of surgery with postoperative radiotherapy in locally advanced cervical adenocarcinoma: a population-based analysis.
Wang X; Lu X; Chen J; Yi H; Lan Q
BMC Surg; 2023 Oct; 23(1):299. PubMed ID: 37789291
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the clinical outcomes of patients with stage IA-IIA2 cervical adenocarcinoma and squamous cell carcinoma after radical hysterectomy: A propensity score-matched real-world analysis.
Liang C; Su G; Sun L; Zhao H; Liu P; Chen C
Int J Gynaecol Obstet; 2024 Jan; ():. PubMed ID: 38287671
[TBL] [Abstract][Full Text] [Related]
12. The value of multiparametric MRI combined with clinical prognostic parameters in predicting the 5-year survival of stage IIIC1 cervical squamous cell carcinoma.
Qin F; Pang H; Ma J; Xu H; Yu T; Luo Y; Dong Y
Eur J Radiol; 2023 Dec; 169():111181. PubMed ID: 37939604
[TBL] [Abstract][Full Text] [Related]
13. Role of adjuvant therapy in intermediate-risk cervical cancer patients - Subanalyses of the SCCAN study.
Cibula D; Akilli H; Jarkovsky J; van Lonkhuijzen L; Scambia G; Meydanli MM; Ortiz DI; Falconer H; Abu-Rustum NR; Odetto D; Klát J; Dos Reis R; Zapardiel I; Di Martino G; Presl J; Laky R; López A; Weinberger V; Obermair A; Pareja R; Poncová R; Mom C; Bizzarri N; Borčinová M; Aslan K; Salcedo Hernandez RA; Fons G; Benešová K; Dostálek L; Ayhan A
Gynecol Oncol; 2023 Mar; 170():195-202. PubMed ID: 36706646
[TBL] [Abstract][Full Text] [Related]
14. Intraoperative implantation of 125I seeds improves prognosis in refractory stage IIIB cervical cancer: a case report and literature review.
Wu J; Tang J; Luo Y; Li W; Liu Y; Xiao L
BMC Womens Health; 2024 Mar; 24(1):153. PubMed ID: 38431586
[TBL] [Abstract][Full Text] [Related]
15. Survival Outcomes of Patients With Stage IB3 Cervical Cancer Who Undergo Abdominal Radical Hysterectomy Versus Radiochemotherapy.
Li Z; Yang Q; Guo J; Liang G; Duan H; Wang S; Hao M; Liang W; Li D; Zhan X; Xie Q; Lang J; Liu P; Chen C
Front Oncol; 2022; 12():933755. PubMed ID: 35875125
[TBL] [Abstract][Full Text] [Related]
16. Disparities in Survival Outcomes Between Locally Advanced Cervical Squamous Cell Carcinoma and Adenocarcinoma Treated with Chemoradiotherapy.
Hong SS; Li Y; Lin YY; Wu SG; Chen LY; Zhou J
Int J Womens Health; 2024; 16():401-410. PubMed ID: 38463686
[TBL] [Abstract][Full Text] [Related]
17. Stratified Prognostic Comparison Between Stage IIB-IVA Cervical Adenocarcinoma and Squamous Cell Carcinoma: A SEER Database-Based Study.
Guo H; Gao S; Kong W
Int J Womens Health; 2024; 16():579-590. PubMed ID: 38596195
[TBL] [Abstract][Full Text] [Related]
18. Real-world efficacy of adjuvant therapy for totally resected stage I lung adenocarcinoma patients with pathological high-risk factors: propensity score analysis.
Zhao K; Yang L; Liu L; Wang G; Zhang J; Gao X; Guo C; Huang C; Chen Y; Li S
BMC Surg; 2024 May; 24(1):140. PubMed ID: 38720305
[TBL] [Abstract][Full Text] [Related]
19. Local hyperthermia with built-in endoscopy for radioresistant cervical cancer: a case series.
Yoshikawa N; Itoh Y; Matsukawa T; Kawamura M; Yamada K; Nakamura S; Kajiyama H
Nagoya J Med Sci; 2023 Aug; 85(3):639-647. PubMed ID: 37829486
[TBL] [Abstract][Full Text] [Related]
20. L1CAM Is Not a Predictive Factor in Early-stage Squamous-cell Cervical Cancer.
Romanová M; Židlík V; Javůrková V; Kondé A; Šimetka O; Klát J
In Vivo; 2023; 37(5):2334-2339. PubMed ID: 37652517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
